Literature DB >> 23588568

Lazy sunday afternoons: the negative impact of interruptions in patients' daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data.

M Vervloet1, P Spreeuwenberg, M L Bouvy, E R Heerdink, D H de Bakker, L van Dijk.   

Abstract

PURPOSE: Considerable variability in adherence over time exists. The aim of this study was to investigate to what extent deviations from the prescribed regimen in type 2 diabetes patients can be explained by characteristics of the individual 'medication intake moments' and the patient.
METHODS: Medication intake of 104 non-adherent type 2 diabetes patients from 37 community pharmacies was electronically monitored for 6 months. The primary outcome measures were: (1) whether or not the intake occurred and (2) whether or not the intake occurred within the agreed-upon time period (correct timing). Multilevel logistic regression analyses were performed to account for the nested structure of the data.
RESULTS: Medication intakes in the evening and during weekends and holidays were more likely to be incorrectly timed and also more likely to be completely missed. Irrespective of timing, most intakes occurred in the mornings of Monday through Thursday (96 %), and least intakes occurred on Saturday evening (82 %). Correctly timed intakes most often occurred on Monday and Tuesday mornings (61 %) in contrast to Sunday evenings (33 %). A patient's medication regimen was significantly associated with adherence.
CONCLUSION: Based on our results, among patients who already have difficulties in taking their oral antidiabetic medication, interruptions in the daily routine negatively influence the intake of their medication. Professionals need to be aware of this variation in adherence within patients. As regular medication intake is important to maintain glycaemic control, healthcare professionals and patients should work together to find strategies that prevent deviations from the prescribed regimen at these problematic dosing times.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588568     DOI: 10.1007/s00228-013-1511-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  A systematic review of the associations between dose regimens and medication compliance.

Authors:  A J Claxton; J Cramer; C Pierce
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

2.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

3.  Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics.

Authors:  Laetitia Comté; Bernard Vrijens; Eric Tousset; Paul Gérard; John Urquhart
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-05-12       Impact factor: 2.745

4.  Do we need full compliance data for population pharmacokinetic analysis?

Authors:  P Girard; L B Sheiner; H Kastrissios; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1996-06

5.  Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.

Authors:  A Rubio; C Cox; M Weintraub
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

6.  Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas.

Authors:  Annette Winkler; Adrian U Teuscher; Bruno Mueller; Peter Diem
Journal:  Swiss Med Wkly       Date:  2002-07-13       Impact factor: 2.193

7.  SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored.

Authors:  M Vervloet; L van Dijk; J Santen-Reestman; B van Vlijmen; P van Wingerden; M L Bouvy; D H de Bakker
Journal:  Int J Med Inform       Date:  2012-05-30       Impact factor: 4.046

8.  Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy.

Authors:  Avani C Modi; Joseph R Rausch; Tracy A Glauser
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

9.  Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders.

Authors:  Marcia Vervloet; Liset van Dijk; Jacqueline Santen-Reestman; Bas van Vlijmen; Marcel L Bouvy; Dinny H de Bakker
Journal:  BMC Health Serv Res       Date:  2011-01-10       Impact factor: 2.655

10.  Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics.

Authors:  Liset van Dijk; Eibert R Heerdink; Dinesh Somai; Sandra van Dulmen; Emmy M Sluijs; Denise T de Ridder; Anna M G F Griens; Jozien M Bensing
Journal:  BMC Health Serv Res       Date:  2007-04-10       Impact factor: 2.655

View more
  6 in total

1.  Success of a sustained pharmaceutical care service with electronic adherence monitoring in patient with diabetes over 12 months.

Authors:  Fabienne Boeni; Kurt E Hersberger; Isabelle Arnet
Journal:  BMJ Case Rep       Date:  2015-06-02

2.  Text-message reminders plus incentives increase adherence to antidiabetic medication in adults with type 2 diabetes.

Authors:  Bethany R Raiff; Brantley P Jarvis; Jesse Dallery
Journal:  J Appl Behav Anal       Date:  2016-07-14

3.  Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention.

Authors:  Sarah S Dermody; Jeffery D Wardell; Susan A Stoner; Christian S Hendershot
Journal:  Ann Behav Med       Date:  2018-08-16

4.  Patients' beliefs about adherence to oral antidiabetic treatment: a qualitative study.

Authors:  Line Guénette; Sophie Lauzier; Laurence Guillaumie; Gabriel Giguère; Jean-Pierre Grégoire; Jocelyne Moisan
Journal:  Patient Prefer Adherence       Date:  2015-03-10       Impact factor: 2.711

5.  Factors Associated With Nonadherence to Cardiovascular Medications: A Cross-sectional Study.

Authors:  Danielle M van der Laan; Petra J M Elders; Christel C L M Boons; Giel Nijpels; Jacqueline G Hugtenburg
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

Review 6.  Medication management needs information and communications technology-based approaches, including telehealth and artificial intelligence.

Authors:  Alphons Eggerth; Dieter Hayn; Günter Schreier
Journal:  Br J Clin Pharmacol       Date:  2019-07-25       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.